-
ZMapp is an
experimental biopharmaceutical medication comprising three chimeric monoclonal antibodies under development as a
treatment for
Ebola virus...
- Diego, California. It is
responsible for the
research and
development of
ZMapp, a drug
which is still[when?]
under development and
comprises three humanized...
- and
other scientists called for the
emergency release of the
experimental ZMapp vaccine for use on
humans before it had
undergone clinical testing on humans...
- drug
ZMapp. They both recovered, but
there was no
confirmation or
proof that the drug was a factor. A
Spanish priest with
Ebola had
taken ZMapp but died...
- 2015
Ebola epidemic with the use, by
prescription and authorization, of
ZMapp and
other experimental treatments, and for new
drugs that can be used to...
- mAb114 and REGN-EB3 were
superior to the
comparator ZMapp.
Overall mortality of
patients in the
ZMapp and
Remdesivir groups were 49% and 53%
compared to...
-
doses of
ZMapp,[citation needed] a drug for
Ebola virus disease treatment originally developed by Mapp Biopharmaceutical.
Supplies of
ZMapp ran out in...
- FGI-104 FGI-106 JK-05
Lamivudine mAb114 TKM-Ebola (failed)
Triazavirin ZMapp Vaccines cAd3-ZEBOV
Drugs Vaccines rVSV-ZEBOV
Notable people Ebola researchers...
- who
received ZMapp, the
difference was not
statistically significant and
ultimately it
could not be
determined whether the use of
ZMapp was
superior to...
-
Midwest Reliability Organization Mapp Biopharmaceutical,
manufacturers of
ZMapp Ebola vaccine Mapp and Lucia, a
series of
novels featuring Miss Mapp MAPP...
